本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

SAB Biotherapeutics, Inc.

1.96
+0.240013.95%
盘后1.95-0.0100-0.51%19:45 EDT
成交量:9.02万
成交额:17.43万
市值:1,821.17万
市盈率:-0.53
高:2.10
开:1.78
低:1.75
收:1.72
数据加载中...
2021/11/01

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/10/28

重要事件披露

8-K - Current report
2021/10/22

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/10/21

重要事件披露

8-K - Current report
2021/10/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/13

重要事件披露

8-K - Current report
2021/10/13

企业合并公告

425 - Prospectuses and communications, business combinations
2021/10/12

重要事件披露

8-K - Current report
2021/10/12

企业合并公告

425 - Prospectuses and communications, business combinations
2021/10/07

企业合并公告

425 - Prospectuses and communications, business combinations
2021/10/04

企业合并公告

425 - Prospectuses and communications, business combinations
2021/09/28

企业合并公告

425 - Prospectuses and communications, business combinations
2021/09/27

企业合并公告

425 - Prospectuses and communications, business combinations
2021/09/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/22

企业合并公告

425 - Prospectuses and communications, business combinations
2021/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/16

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/08

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/08

企业合并公告

425 - Prospectuses and communications, business combinations
2021/09/07

企业合并公告

425 - Prospectuses and communications, business combinations